Whitebox Advisors’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Whitebox Advisors’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,000	Closed	-$1.88K	–	551
2023 Q1	$1.88K	Hold	25,000	–	–	﹤0.01%	508
2022 Q4	$128	Hold	25,000	–	–	﹤0.01%	763
2022 Q3	$2K	Hold	25,000	–	–	﹤0.01%	863
2022 Q2	$3K	Hold	25,000	–	–	﹤0.01%	833
2022 Q1	$9K	Buy	+25,000	New	+$10.1K	﹤0.01%	846

Whitebox Advisors's LVACW Position: Q2 2023 in Review

Whitebox Advisors sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 25,000 shares — an estimated $1.88K sold.

Whitebox Advisors first reported a position in LVACW in Q1 2022 and held it in 5 quarters. The position peaked at $9K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Whitebox Advisors reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Whitebox Advisors sold 25,000 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $1.88K.
Whitebox Advisors first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
Whitebox Advisors's LAVA Medtech Acquisition Corp. Warrants position peaked at $9K in Q1 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Whitebox Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.